Bayer Launches Phase I Study of BAY 3670549 for Atrial Fibrillation
CompanyDrug

Bayer Launches Phase I Study of BAY 3670549 for Atrial Fibrillation

InnoCare Pharma's Minjuvi Gains NMPA Approval for DLBCL Treatment
CompanyDrug

InnoCare Pharma’s Minjuvi Gains NMPA Approval for DLBCL Treatment

Uni-Bio Science's Generic Diquas Accepted for NMPA Review
CompanyDrug

Uni-Bio Science’s Generic Diquas Accepted for NMPA Review

MicusRx's Contezolid Sodium NDA Accepted for Review by NMPA
CompanyDrug

MicusRx’s Contezolid Sodium NDA Accepted for Review by NMPA

Sanofi to Acquire Vigil Neuroscience to Boost Neurology Pipeline
CompanyDeals

Sanofi to Acquire Vigil Neuroscience to Boost Neurology Pipeline

Eli Lilly's Kisunla Approved in Australia for Alzheimer's Treatment
CompanyDrug

Eli Lilly’s Kisunla Approved in Australia for Alzheimer’s Treatment

INT Medical Instruments Endonom Medical Acquisition
CompanyDeals

Shanghai INT Medical Instruments to Acquire Majority Stake in Endonom Medical

Medtronic Reports Q4 and FY2025 Results with Revenue Growth Across Key Segments
Company

Medtronic Reports Q4 and FY2025 Results with Revenue Growth Across Key Segments

Genentech and Orionis Enter Second Collaboration on Small-Molecule Oncology Drugs
CompanyDeals

Genentech and Orionis Enter Second Collaboration on Small-Molecule Oncology Drugs

Kexing Biopharm's GB18 Receives FDA Approval for Tumor Cachexia Clinical Trial
CompanyDrug

Kexing Biopharm’s GB18 Receives FDA Approval for Tumor Cachexia Clinical Trial

Accropeutics' AC-201 Shows Positive Phase II Results in Psoriasis Treatment
CompanyDrug

Accropeutics’ AC-201 Shows Positive Phase II Results in Psoriasis Treatment

Simcere's FGFR2b-Targeting ADC SIM0686 Enters Phase I Clinical Study
CompanyDrug

Simcere’s FGFR2b-Targeting ADC SIM0686 Enters Phase I Clinical Study